HSD17B4 and retinal disorder: This dual approach will be necessary to prevent both the early onset (i.e., reduced retinal DHA levels, due to impaired systemic supply) and late retinopathy (i.e., impaired handling of the VLC-PUFA–containing POS due to the cell-autonomous role of MFP2 in the RPE).